During the past decade, St Stephen's Centre conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St Stephen's Centre" #1 sponsor was "St Stephens Aids Trust" with 22 trials, followed by "International AIDS Vaccine Initiative" with 2 trials sponsored, "Kirby Institute" with 2 trials sponsored, "ANRS, Emerging Infectious Diseases" with 1 trials sponsored and "Abbott" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St Stephen's Centre" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Imperial College London" with 2 trials as a collaborator, "University of Liverpool" with 2 trials as a collaborator, "ViiV Healthcare" with 2 trials as a collaborator and "Centre Hospitalier Universitaire Vaudois" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "St Stephen's Centre" are "HIV Infections" (14 trials), "HIV" (10 trials), "HIV Infection" (6 trials), "Acquired Immunodeficiency Syndrome" (1 trials) and "HIV-1" (1 trials). Many other conditions were trialed in "St Stephen's Centre" in a lesser frequency.

Most popular intervention types in "St Stephen's Centre" are "Drug" (23 trials), "Biological" (5 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Maraviroc" (3 trials), "Rezolsta" (2 trials), "+/- 200mg NANO-Lopinavir" (1 trials), "+/- 200mg ritonavir NORVIR" (1 trials) and "100mg Ritonavir" (1 trials). Other intervention names were less common.

The vast majority of trials in "St Stephen's Centre" are 26 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "St Stephen's Centre". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in St Stephen's Centre, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in St Stephen's Centre, 19 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".